We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Iq-ai Limited | LSE:IQAI | London | Ordinary Share | JE00BD4H0R42 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.55 | 1.50 | 1.60 | 1.55 | 1.55 | 1.55 | 4,020 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Florists | 536k | -512k | -0.0028 | -5.54 | 2.83M |
From Apr 2019 to Apr 2024
TIDMIQAI
RNS Number : 5225L
IQ-AI Limited
30 April 2020
IQ-AI Ltd
("IQ-AI" or the "Company")
31 December 2019 final year results announcement timing
IQ-AI announces that it will delay the announcement of its Final Year 2019 full year results, originally planned for the end of April, until early May. This will also ensure that the Company and its auditors have adequate time to complete their standard procedures given the current working restrictions. This delay is in line with the recent joint regulatory guidance from the FCA, the FRC and the PRA regarding reporting timeframes in the current environment.
The Directors of the Company accept responsibility for the contents of this announcement.
-ENDS-
For further information, please contact:
IQ-AI Limited Trevor Brown/Vinod Kaushal/Qu Li Tel: 020 7469 0930 Peterhouse Capital Limited (Financial Adviser and Broker) Lucy Williams/Heena Karani Tel: 020 7220 9797
About IQ-AI Ltd (iq-al.ltd) IQ-AI, Ltd, the parent company of Imaging Biometrics(R) and StoneChecker(TM), is focused on providing advanced and state-of-the-art medical software and related services. Imaging Biometrics develops and provides visualization and analytical solutions enabling clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit imagingbiometrics.com for more information.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
STRKKKBPDBKDBQN
(END) Dow Jones Newswires
April 30, 2020 08:08 ET (12:08 GMT)
1 Year Iq-ai Chart |
1 Month Iq-ai Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
